Albert Selva-O'Callaghan Selected Research

Albert Selva-O'Callaghan Research Topics

Disease

55	Myositis (Idiopathic Inflammatory Myopathies) 01/2024 - 10/2006
23	Neoplasms (Cancer) 12/2023 - 02/2008
22	Dermatomyositis (Dermatopolymyositis) 01/2024 - 01/2007
14	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2024 - 10/2006
12	Muscular Diseases (Myopathy) 01/2024 - 03/2006
8	Polymyositis 02/2023 - 03/2006
7	Inclusion Body Myositis 02/2023 - 01/2007
6	Arthritis (Polyarthritis) 01/2021 - 10/2006
5	Antisynthetase syndrome 02/2023 - 07/2012
4	Systemic Scleroderma (Systemic Sclerosis) 09/2023 - 09/2016
4	Autoimmune Diseases (Autoimmune Disease) 10/2022 - 03/2006
4	COVID-19 10/2022 - 07/2020
3	Rheumatoid Arthritis 02/2023 - 01/2018
3	Deglutition Disorders (Dysphagia) 01/2023 - 10/2006
3	Mixed Connective Tissue Disease (MCTD) 01/2021 - 09/2016
2	Sjogren's Syndrome (Sjogren Syndrome) 02/2023 - 10/2006
2	Myocarditis (Carditis) 01/2023 - 07/2021
2	Connective Tissue Diseases (Connective Tissue Disease) 11/2021 - 06/2007
2	Pneumonia (Pneumonitis) 11/2021 - 11/2021
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2014
2	Inflammation (Inflammations) 01/2020 - 03/2006
1	Calcinosis 09/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2023
1	Hypersensitivity (Allergy) 01/2023
1	Heart Diseases (Heart Disease) 01/2023
1	Muscular Atrophy (Muscle Atrophy) 01/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Second Primary Neoplasms (Neoplasms, Second) 01/2022
1	Idiopathic Pulmonary Fibrosis 11/2021
1	Amyopathic dermatomyositis 01/2021
1	Asthenia 02/2020
1	Muscle Weakness 02/2020
1	Undifferentiated Connective Tissue Diseases 01/2020
1	Raynaud Disease (Raynaud's Disease) 01/2019

Drug/Important Bio-Agent (IBA)

34	AutoantibodiesIBA 01/2024 - 10/2006
24	AntibodiesIBA 01/2024 - 10/2006
7	Ligases (Synthetase)IBA 01/2024 - 06/2009
6	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2010
6	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2019
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2009
4	Oxidoreductases (Dehydrogenase)IBA 01/2022 - 01/2015
3	Immune Checkpoint InhibitorsIBA 08/2023 - 02/2020
3	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022 - 04/2015
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2021 - 05/2013
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2020 - 01/2015
3	transcriptional intermediary factor 1IBA 01/2020 - 06/2012
2	AutoantigensIBA 01/2024 - 01/2019
2	Immunoglobulins (Immunoglobulin)IBA 01/2024 - 07/2020
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2023 - 09/2011
2	CortactinIBA 01/2022 - 10/2014
2	Signal Recognition ParticleIBA 01/2022 - 11/2021
2	Mi-2 antibodiesIBA 01/2022 - 10/2006
2	Transfer RNA (tRNA)IBA 11/2019 - 07/2012
2	Tumor Biomarkers (Tumor Markers)IBA 11/2018 - 06/2010
2	Rituximab (Mabthera)FDA Link 09/2016 - 07/2011
1	Nuclear RNAIBA 01/2024
1	Valosin Containing ProteinIBA 09/2023
1	Sp4 Transcription FactorIBA 02/2023
1	Interferon-gamma (Interferon, gamma)IBA 01/2023
1	Deoxyribonuclease I (Nickase)IBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	Interferon Type IIBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	trioctyl phosphine oxide (TOPO)IBA 01/2023
1	BNT162 VaccineIBA 10/2022
1	VaccinesIBA 10/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	imidazole mustard (BIC)IBA 01/2022
1	Coenzyme A (CoA)IBA 01/2022
1	EnzymesIBA 01/2022
1	ImmunosorbentsIBA 01/2022
1	Mucin-1 (CA 15-3 Antigen)IBA 11/2021
1	pembrolizumabIBA 07/2021
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021
1	RibonucleoproteinsIBA 01/2021
1	Eukaryotic Initiation Factor-2B (Eukaryotic Initiation Factor 2B)IBA 01/2021
1	Janus Kinase InhibitorsIBA 07/2020
1	CalcineurinIBA 07/2020
1	Antimalarials (Antimalarial Agents)IBA 07/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 07/2020
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2020
1	Cell Adhesion Molecule-1IBA 01/2020
1	apolipoprotein A-IV (apolipoprotein AIV)IBA 01/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 11/2019
1	DNA (Deoxyribonucleic Acid)IBA 11/2019
1	Muscle Proteins (Muscle Protein)IBA 01/2019
1	Antinuclear AntibodiesIBA 01/2019
1	InterferonsIBA 01/2019
1	Cell-Free Nucleic AcidsIBA 11/2018

Therapy/Procedure

9	Therapeutics 11/2021 - 02/2008
2	Immunotherapy 01/2022 - 11/2019
2	Biological Therapy 02/2018 - 09/2014
1	Lasers (Laser) 01/2023
1	Immunomodulation 07/2020